Pacira Pharmaceuticals to Present at the 2017 H.C. Wainwright 19th Annual Global Investment Conference

PARSIPPANY, N.J., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. PCRX today announced that members of its management team are scheduled to present at the 2017 H.C. Wainwright 19^th Annual Global Investment Conference at 10:50 AM ET on Monday, September 11, 2017 in New York City.

A live audio webcast of the Pacira presentation can be accessed by visiting the "Investors & Media" section of the company's website at investor.pacira.com. A replay of the webcast will be archived on the Pacira website for two weeks following the presentation date.

About Pacira                                                                           

Pacira Pharmaceuticals, Inc. PCRX is a specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company's flagship product, EXPAREL^® (bupivacaine liposome injectable suspension), indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia, was commercially launched in the United States in April 2012. EXPAREL and two other products have successfully utilized DepoFoam^®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. Additional information about Pacira is available at www.pacira.com.

Company Contact:
Pacira Pharmaceuticals, Inc.
Susan Mesco 
(973) 451-4030
Susan.mesco@pacira.com